Emerging Global Technologies appointed authorized distributor for Annalise.ai

Emerging Global Technologies (EGT), a leading provider of innovative technology solutions, is thrilled to announce its recent collaboration with Annalise.ai, the Sydney-headquartered radiology artificial intelligence (AI) solution provider.

EGT has now been appointed as an authorized distributor for Annalise.ai’s groundbreaking solutions in the United Arab Emirates (UAE) and other Gulf Cooperation Council (GCC) countries.

Annalise.ai’s sophisticated AI technologies have garnered acclaim for their precision and comprehensiveness in aiding diagnostic processes, offering healthcare professionals powerful tools to improve patient care. Through this partnership, Emerging Global Technologies will play a pivotal role in expanding the accessibility of Annalise.ai’s solutions to medical institutions, clinics, and healthcare providers in the GCC.

Dimitry Tran – Co-founder and Board Director at Annalise.ai expressed enthusiasm about the partnership, stating, “We are excited to welcome Emerging Global Technologies to the Partner Program covering the Middle East. This partnership will enable Annalise.ai to expand coverage within the region and provide access to our award-winning solutions, supported by the sales and technical expertise of Emerging Global Technologies.”

Sassine Mazraani – Chief Executive Officer at Emerging Global Technologies, shared his perspective on the partnership, saying, “EGT is excited to be associated with Annalise.ai, a leader in AI solutions for medical imaging. This collaboration reinforces our commitment to providing state-of-the-art technologies to the healthcare sector in the GCC. We believe that the integration of Annalise.ai’s AI expertise with our extensive network and expertise will lead to groundbreaking advancements in healthcare across the region.”

Annalise.ai distinguishes itself as a leading provider of comprehensive radiology solutions. With the ability to identify up to 124 findings on chest radiographs and up to 130 findings on non-contrast head CT, along with its detailed draft reports, this solution effortlessly integrates into existing workflows.

The partnership between EGT and Annalise.ai signifies a joint commitment to driving innovation and improving patient care through the integration of artificial intelligence in the medical field. This collaboration is set to empower healthcare professionals with advanced decision-support tools, ultimately leading to more accurate diagnoses and enhanced patient outcomes.

For more information about Emerging Global Technologies and Annalise AI,
please visit www.egtmea.com and www.annalise.ai, respectively.

About Emerging Global Technologies

Emerging Global Technologies, your trusted healthcare technology partner in the MENA region. With over two decades of experience, we are recognized as an innovative, forward-looking company dedicated to revolutionizing the healthcare technology landscape. As pioneers in the field, we introduced voice recognition, Digital ID, Single Sign-on, and are now at the forefront of AI with predictive diagnosis and life-saving solutions. Our client-centric approach focuses on delivering tailored solutions, and our commitment to continuous development ensures our team is equipped with the latest technologies.

About Annalise.ai

Annalise.ai is a global health-tech firm that has touched the lives of millions across the globe. Our patient-first approach is proudly clinician-led and comes from a deep understanding of the challenges faced in medical imaging. Our AI provides clinicians with a second set of eyes, allowing them to review radiological studies with confidence and deliver better health outcomes for patients. With accelerating advances in medical imaging technology, radiologists and other healthcare providers are now expected to diagnose patients quickly and accurately. Annalise.ai fuses the highest quality imaging data with the very best in computer science to produce comprehensive AI clinical decision support solutions, empowering clinicians to make accurate decisions, faster. Today Annalise.ai is cleared to be used in 40+ countries.